Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling
Abstract Oncostatin M (OSM) has pleiotropic effects on various inflammatory diseases, including kidney stone disease. The prevalence of kidney stones has increased worldwide, despite recent therapeutic advances, due to its high recurrence rate, suggesting the importance of prevention of repeated rec...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-11-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-024-80411-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841559440659054592 |
|---|---|
| author | Ryusuke Deguchi Tadasuke Komori Shimpei Yamashita Tomoko Hisaoka Mizuki Kajimoto Yasuo Kohjimoto Isao Hara Yoshihiro Morikawa |
| author_facet | Ryusuke Deguchi Tadasuke Komori Shimpei Yamashita Tomoko Hisaoka Mizuki Kajimoto Yasuo Kohjimoto Isao Hara Yoshihiro Morikawa |
| author_sort | Ryusuke Deguchi |
| collection | DOAJ |
| description | Abstract Oncostatin M (OSM) has pleiotropic effects on various inflammatory diseases, including kidney stone disease. The prevalence of kidney stones has increased worldwide, despite recent therapeutic advances, due to its high recurrence rate, suggesting the importance of prevention of repeated recurrence in the treatment of kidney stone disease. Using a mouse model of renal crystal formation, we investigated the preventive effects of blockade of OSM receptor β (OSMRβ) signaling on the development of kidney stone disease by treatment with a monoclonal anti-OSMRβ antibody that we generated. The anti-OSMRβ antibody abrogated OSM-induced phosphorylation of STAT3 and expression of crystal-binding molecules (Opn, Anxa1, Anxa2) and inflammation/fibrosis-associated molecules (Tnfa, Tgfb, Col1a2) in renal tubular epithelial cells and fibroblasts. In glyoxylate-injected mice, a mouse model of renal crystal formation, there was significant suppression of crystal deposits and expression of crystal-binding molecules (Opn, Anxa1, Anxa2), a tubular injury marker (Kim-1), and inflammation/fibrosis-associated molecules (Tnfa, Il1b, Mcp-1, Tgfb, Col1a2) in the kidneys of the anti-OSMRβ antibody-treated mice, compared with those in vehicle- or isotype control antibody-treated mice. In addition, treatment with the anti-OSMRβ antibody significantly decreased infiltrating macrophages and fibrosis in the kidneys. These findings suggest that anti-OSMRβ antibody-treatment may be effective in preventing kidney stone disease. |
| format | Article |
| id | doaj-art-7a10275d90a042f5b79ee8d7d03bfce8 |
| institution | Kabale University |
| issn | 2045-2322 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj-art-7a10275d90a042f5b79ee8d7d03bfce82025-01-05T12:28:36ZengNature PortfolioScientific Reports2045-23222024-11-0114111110.1038/s41598-024-80411-4Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signalingRyusuke Deguchi0Tadasuke Komori1Shimpei Yamashita2Tomoko Hisaoka3Mizuki Kajimoto4Yasuo Kohjimoto5Isao Hara6Yoshihiro Morikawa7Department of Urology, Wakayama Medical UniversityDepartment of Anatomy & Neurobiology, Wakayama Medical UniversityDepartment of Urology, Wakayama Medical UniversityDepartment of Anatomy & Neurobiology, Wakayama Medical UniversityDepartment of Anatomy & Neurobiology, Wakayama Medical UniversityDepartment of Urology, Wakayama Medical UniversityDepartment of Urology, Wakayama Medical UniversityDepartment of Anatomy & Neurobiology, Wakayama Medical UniversityAbstract Oncostatin M (OSM) has pleiotropic effects on various inflammatory diseases, including kidney stone disease. The prevalence of kidney stones has increased worldwide, despite recent therapeutic advances, due to its high recurrence rate, suggesting the importance of prevention of repeated recurrence in the treatment of kidney stone disease. Using a mouse model of renal crystal formation, we investigated the preventive effects of blockade of OSM receptor β (OSMRβ) signaling on the development of kidney stone disease by treatment with a monoclonal anti-OSMRβ antibody that we generated. The anti-OSMRβ antibody abrogated OSM-induced phosphorylation of STAT3 and expression of crystal-binding molecules (Opn, Anxa1, Anxa2) and inflammation/fibrosis-associated molecules (Tnfa, Tgfb, Col1a2) in renal tubular epithelial cells and fibroblasts. In glyoxylate-injected mice, a mouse model of renal crystal formation, there was significant suppression of crystal deposits and expression of crystal-binding molecules (Opn, Anxa1, Anxa2), a tubular injury marker (Kim-1), and inflammation/fibrosis-associated molecules (Tnfa, Il1b, Mcp-1, Tgfb, Col1a2) in the kidneys of the anti-OSMRβ antibody-treated mice, compared with those in vehicle- or isotype control antibody-treated mice. In addition, treatment with the anti-OSMRβ antibody significantly decreased infiltrating macrophages and fibrosis in the kidneys. These findings suggest that anti-OSMRβ antibody-treatment may be effective in preventing kidney stone disease.https://doi.org/10.1038/s41598-024-80411-4 |
| spellingShingle | Ryusuke Deguchi Tadasuke Komori Shimpei Yamashita Tomoko Hisaoka Mizuki Kajimoto Yasuo Kohjimoto Isao Hara Yoshihiro Morikawa Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling Scientific Reports |
| title | Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling |
| title_full | Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling |
| title_fullStr | Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling |
| title_full_unstemmed | Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling |
| title_short | Suppression of renal crystal formation, inflammation, and fibrosis by blocking oncostatin M receptor β signaling |
| title_sort | suppression of renal crystal formation inflammation and fibrosis by blocking oncostatin m receptor β signaling |
| url | https://doi.org/10.1038/s41598-024-80411-4 |
| work_keys_str_mv | AT ryusukedeguchi suppressionofrenalcrystalformationinflammationandfibrosisbyblockingoncostatinmreceptorbsignaling AT tadasukekomori suppressionofrenalcrystalformationinflammationandfibrosisbyblockingoncostatinmreceptorbsignaling AT shimpeiyamashita suppressionofrenalcrystalformationinflammationandfibrosisbyblockingoncostatinmreceptorbsignaling AT tomokohisaoka suppressionofrenalcrystalformationinflammationandfibrosisbyblockingoncostatinmreceptorbsignaling AT mizukikajimoto suppressionofrenalcrystalformationinflammationandfibrosisbyblockingoncostatinmreceptorbsignaling AT yasuokohjimoto suppressionofrenalcrystalformationinflammationandfibrosisbyblockingoncostatinmreceptorbsignaling AT isaohara suppressionofrenalcrystalformationinflammationandfibrosisbyblockingoncostatinmreceptorbsignaling AT yoshihiromorikawa suppressionofrenalcrystalformationinflammationandfibrosisbyblockingoncostatinmreceptorbsignaling |